CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165,388 | -30.1% | 39,378 | 0.0% | 0.00% | – |
| Q4 2022 | $236,662 | +7.8% | 39,378 | +4.4% | 0.00% | – |
| Q3 2022 | $219,565 | -4.8% | 37,726 | -2.3% | 0.00% | – |
| Q2 2022 | $230,526 | -2.3% | 38,614 | -18.6% | 0.00% | – |
| Q2 2018 | $236,000 | +2260.0% | 47,439 | +1694.2% | 0.00% | – |
| Q1 2018 | $10,000 | +42.9% | 2,644 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | +600.0% | 2,644 | +787.2% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 298 | -59.2% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 731 | +34.6% | 0.00% | – |
| Q1 2017 | $2,000 | – | 543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|